Impact of Next-Generation Sequencing on Outcomes in Hepatocellular Carcinoma: How Precise Are We Really?

Abstract excerpt

Advances in Next-Generation Sequencing (NGS) technology have led to a rapid expansion in the application of "precision medicine," attempting to personalize therapies and improve outcomes for cancer patients. While these technologies carry great promise, evidence for translation to patient outcomes is lacking. This is especially true in hepatocellular carcinoma (HCC), where multiple factors have hampered efforts...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Hepatocellular Carcinoma Treatment and Prognosis
• Share to Pancreatic and Hepatic Oncology Research